These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2594921)

  • 1. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity.
    Kelley AE; Bakshi VP; Delfs JM; Lang CG
    Psychopharmacology (Berl); 1989; 99(4):542-9. PubMed ID: 2594921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum.
    Kelley AE; Delfs JM
    Neuroscience; 1994 May; 60(1):85-95. PubMed ID: 7914360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat.
    Salamone JD; Johnson CJ; McCullough LD; Steinpreis RE
    Psychopharmacology (Berl); 1990; 102(4):529-34. PubMed ID: 2096410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the cholinergic system in haloperidol-induced release of dopamine from slices of striatum in the rat.
    Yamada S; Nishi S; Kojima H; Yokoo H; Tsutsumi T; Inanaga K
    Neuropharmacology; 1990 Jan; 29(1):55-9. PubMed ID: 2304616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.
    Rupniak NM; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1983; 79(2-3):226-30. PubMed ID: 6133305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
    Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
    Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.
    Murugaiah KD; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):294-300. PubMed ID: 13680087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased postsynaptic dopaminergic and cholinergic functions in the ventrolateral striatum of spontaneously hypertensive rat.
    Fujita S; Adachi K; Lee J; Uchida T; Koshikawa N; Cools AR
    Eur J Pharmacol; 2004 Jan; 484(1):75-82. PubMed ID: 14729384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic/dopaminergic interaction in the rat striatum assessed from drug-induced repetitive oral movements.
    Kikuchi de Beltrán K; Koshikawa N; Saigusa T; Watanabe K; Koshida Y; Kobayashi M
    Eur J Pharmacol; 1992 Apr; 214(2-3):181-9. PubMed ID: 1516638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms.
    Friedman E; Wang HY; Butkerait P
    Neuropharmacology; 1990 Jun; 29(6):537-44. PubMed ID: 2200974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms.
    Jicha GA; Salamone JD
    J Neurosci; 1991 Dec; 11(12):3822-9. PubMed ID: 1744692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1988; 95(4):502-6. PubMed ID: 2463651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors.
    Adachi K; Hasegawa M; Ikeda H; Sato M; Koshikawa N; Cools AR
    Eur J Pharmacol; 2003 Mar; 464(2-3):147-54. PubMed ID: 12620507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison.
    Herrera-Meza G; Manzo J; Hernández ME; Miquel M; García LI
    Neurologia; 2014 Sep; 29(7):416-22. PubMed ID: 24332783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.
    Ushijima I; Yamada K; Furukawa T
    Psychopharmacology (Berl); 1984; 82(4):301-5. PubMed ID: 6427818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1989; 98(3):372-9. PubMed ID: 2568657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.